Dupont Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Dupont Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,951	Closed	-$141K	–	1564
2022 Q2	$141K	Hold	7,951	–	–	0.01%	1092
2022 Q1	$162K	Sell	7,951 -704	-8%	-$13.3K	0.01%	1138
2021 Q4	$162K	Sell	8,655 -3,452	-29%	-$67.3K	0.01%	1186
2021 Q3	$239K	Sell	12,107 -1,712	-12%	-$37K	0.01%	1177
2021 Q2	$327K	Hold	13,819	–	–	0.01%	1168
2021 Q1	$328K	Sell	13,819 -2,834	-17%	-$67.3K	0.01%	1113
2020 Q4	$334K	Sell	16,653 -1,243	-7%	-$24.3K	0.01%	1004
2020 Q3	$373K	Buy	17,896 +5,914	+49%	+$107K	0.01%	898
2020 Q2	$210K	Sell	11,982 -6,853	-36%	-$134K	﹤0.01%	1108
2020 Q1	$308K	Buy	+18,835	New	+$389K	0.01%	849

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dupont Capital Management's COLL Position: Q3 2022 in Review

Dupont Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 7,951 shares — an estimated $141K sold.

Dupont Capital Management first reported a position in COLL in Q1 2020 and held it in 10 quarters. The position peaked at $373K in Q3 2020. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

Dupont Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Dupont Capital Management sold 7,951 Collegium Pharmaceutical shares in Q3 2022, an estimated $141K.
Dupont Capital Management first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 10 quarters.
Dupont Capital Management's Collegium Pharmaceutical position peaked at $373K in Q3 2020.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Dupont Capital Management's 13F filing for Q3 2022, filed 31 Oct 2022.